APA (7th ed.) Citation

Patoulias, D., & Avranas, K. (2018). Sodium-glucose cotransporter 2 inhibitors and the risk of diabetic ketoacidosis: From pathophysiology to clinical practice. Cardiovascular & hematological disorders, drug targets, 18, . https://doi.org/10.2174/1871529X18666180206123149

Chicago Style (17th ed.) Citation

Patoulias, Dimitrios, and Konstantinos Avranas. "Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis: From Pathophysiology to Clinical Practice." Cardiovascular & Hematological Disorders, Drug Targets 18 (2018). https://doi.org/10.2174/1871529X18666180206123149.

MLA (9th ed.) Citation

Patoulias, Dimitrios, and Konstantinos Avranas. "Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis: From Pathophysiology to Clinical Practice." Cardiovascular & Hematological Disorders, Drug Targets, vol. 18, 2018, https://doi.org/10.2174/1871529X18666180206123149.